Crossmark

The current role and future directions of circulating tumor cells and circulating tumor DNA in urothelial carcinoma of the bladder

Crossref DOI link: https://doi.org/10.1007/s00345-018-2543-9

Published Online: 2018-10-26

Published Print: 2019-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rink, Michael

Schwarzenbach, Heidi

Riethdorf, Sabine

Soave, Armin
License Information

Text and Data Mining valid from 2018-10-26
More Information

Article History

Received: 21 June 2018

Accepted: 22 October 2018

First Online: 26 October 2018

Compliance with ethical standards

:

: Dr. Michael Rink received honoraria by BMS and Pfizer. Dr. Michael Rink is investigator for the following companies and receives research grants by the following companies: Pfizer, MSD. All other authors have nothing to disclose.

: All authors consented to the final draft.